Effect of Maternal Preeclampsia on Hematological Profile of Newborns in Qatar.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2020
Historique:
received: 09 10 2019
accepted: 24 02 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 17 12 2020
Statut: epublish

Résumé

Preeclampsia is a major cause of pregnancy-related maternal, fetal, and neonatal morbidities and mortalities. We aimed to review the effect of maternal preeclampsia on the hematological profile of newborns in the Qatari population. In this case-control study, we reviewed data and complete blood count results of neonates born to Qatari women diagnosed of preeclampsia in 2017 in comparison with data of a control group. Statistical analysis was done using unpaired t-test, chi-square test, and logistic regression analysis. A total of 108 neonates of women with preeclampsia and 103 neonates of healthy normotensive women were recruited. The mean weight, length, head circumference, placental weight, and gestational age were significantly lower ( We found that there was a positive association between preeclampsia and neonatal thrombocytopenia in the Qatari population. Prematurity, placenta insufficiency, fetal growth restriction, and need for neonatal resuscitation were significantly higher in babies born to women with preeclampsia. We recommend that hematological parameters of neonates of those women should be properly monitored to reduce the chances of developing complications.

Sections du résumé

Background
Preeclampsia is a major cause of pregnancy-related maternal, fetal, and neonatal morbidities and mortalities. We aimed to review the effect of maternal preeclampsia on the hematological profile of newborns in the Qatari population.
Methods
In this case-control study, we reviewed data and complete blood count results of neonates born to Qatari women diagnosed of preeclampsia in 2017 in comparison with data of a control group. Statistical analysis was done using unpaired t-test, chi-square test, and logistic regression analysis.
Results
A total of 108 neonates of women with preeclampsia and 103 neonates of healthy normotensive women were recruited. The mean weight, length, head circumference, placental weight, and gestational age were significantly lower (
Conclusions
We found that there was a positive association between preeclampsia and neonatal thrombocytopenia in the Qatari population. Prematurity, placenta insufficiency, fetal growth restriction, and need for neonatal resuscitation were significantly higher in babies born to women with preeclampsia. We recommend that hematological parameters of neonates of those women should be properly monitored to reduce the chances of developing complications.

Identifiants

pubmed: 32258144
doi: 10.1155/2020/7953289
pmc: PMC7097766
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7953289

Informations de copyright

Copyright © 2020 Mohammad A. A. Bayoumi et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Eur J Pediatr. 2013 Nov;172(11):1501-9
pubmed: 23812509
Am J Perinatol. 1995 Jan;12(1):1-6
pubmed: 7710566
Eur J Pediatr. 1993 Feb;152(2):160-3
pubmed: 8444227
Obstet Gynecol. 2013 Nov;122(5):1122-31
pubmed: 24150027
J Pregnancy. 2011;2011:214365
pubmed: 21547086
Am J Obstet Gynecol. 1991 Aug;165(2):467-73
pubmed: 1714678
J Clin Diagn Res. 2017 Jul;11(7):EC26-EC29
pubmed: 28892906
Expert Rev Pharmacoecon Outcomes Res. 2006 Oct;6(5):541-54
pubmed: 20528501
Indian J Pediatr. 2008 Jun;75(6):571-3
pubmed: 18759083
J Matern Fetal Neonatal Med. 2019 Apr;32(7):1205-1212
pubmed: 29113524
J Pediatr. 1982 Feb;100(2):265-71
pubmed: 7057337

Auteurs

Mohammad A A Bayoumi (MAA)

Neonatal Intensive Care Unit (NICU), Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Abir A H Ali (AAH)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Sara G Hamad (SG)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Alaa A M Ali (AAM)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Einas E Elmalik (EE)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Mohamed M I R Elkalaf (MMIR)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Bassem A A Moustafa (BAA)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Deena A D A Shaltout (DADA)

Department of Medical Education, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Prem Chandra (P)

Medical Research Center, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Lisa J Langtree (LJ)

Medical Records Department, Women's Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Noimot O Olayiwola (NO)

Corporate Communication Department, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH